Aranesp® Monthly Preference Study - 2

PHASE4CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Kidney Disease
Interventions
DRUG

Aranesp®

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY

NCT00117078 - Aranesp® Monthly Preference Study - 2 | Biotech Hunter | Biotech Hunter